company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,238457000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,238457000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,923000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,923000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,237534000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48880000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,274903000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,323783000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-86249000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8690000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18161000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9471000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-76778000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2351000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-79129000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-79129000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-79129000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78827000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,379268000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,379268000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1686000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1686000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,377582000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52923000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,398762000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,451685000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-74103000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2337000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4488000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2151000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-71952000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4122000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-67830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-67830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-67830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.85
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,79782000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.85
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,117455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,117455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,472000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,472000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,116983000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12840000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,105434000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,118274000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1291000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,581000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,857000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1015000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1291000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79866.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79866.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,79866.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,2010-10-28 07:33:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,90032000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,90032000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,435000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,435000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89597000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11632000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,94231000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,105863000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16266000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1328000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14938000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16266000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79626000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79626000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,79626000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2,2009-04-01,2009-06-30,2010-07-28 07:30:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,133675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,133675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,599000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,599000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,133076000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20641000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,125212000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,145853000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2458000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1820000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14597000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14597000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14597000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14597000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82926000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82926000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,459074000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,459074000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2093000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2093000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,456981000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65201000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,489252000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,554453000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-97472000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9118000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2122000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-104468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-104468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-104468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-104468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82926000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.26
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82926000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.26
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.26
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,105979000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,105979000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,372000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,372000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,105607000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15658000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,122043000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,137701000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32094000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2234000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,453000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1781000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 07:31:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,325399000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,325399000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1494000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1494000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,323905000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44560000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,364040000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,408600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-84695000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6660000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1484000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5176000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-89871000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-89871000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-89871000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-89871000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.1
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.1
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.1
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,115886000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,115886000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,405000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,405000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,115481000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14679000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,124526000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,139205000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23724000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2342000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,592000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1750000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81492000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 07:30:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,219420000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,219420000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1122000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1122000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,218298000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28902000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,241997000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,270899000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-52601000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4426000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3395000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81492000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,103534000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,103534000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,717000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,717000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,102817000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14223000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,117471000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,131694000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28877000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2084000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,439000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1645000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,80300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,80300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81169000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,122977000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,122977000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2989000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2989000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,119988000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36349000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,129041000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,165390000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-45402000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,799000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54058000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-615000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-53443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90610000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90610000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,445824000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,445824000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,441608000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,117261000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,529506000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,646767000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-205159000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,21282000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3549000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17733000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-222892000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1132000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-221760000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-221760000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-221760000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90610000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.45
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90610000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.45
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.45
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,450000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,450000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,102383000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32916000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,127924000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,160840000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58457000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4061000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,715000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3346000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61803000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,562000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91046000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91046000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 07:29:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,322847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,322847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1227000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1227000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,321620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80912000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,400465000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,481377000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-159757000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11827000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2750000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9077000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-168834000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-168317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-168317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-168317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91046000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.86
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91046000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.86
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.86
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,456522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,456522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1826000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1826000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,454696000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,101553000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,525677000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,627230000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-172534000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14285000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3388000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10897000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-183431000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-182914000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-182914000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-182914000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91046000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.02
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91046000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.02
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.02
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,107810000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,107810000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,395000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,395000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,107415000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24585000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,143149000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,167734000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-60319000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4047000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,998000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3049000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-63368000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-863000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62505000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62505000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62505000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 07:00:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,220014000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,220014000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,219237000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,272541000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,320537000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-101300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7766000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2035000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5731000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-107031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1079000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-105952000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-105952000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-105952000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.18
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.18
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.18
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,459668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,459668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1748000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1748000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,457920000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,84295000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,519796000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,604091000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-146171000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12458000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9332000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-155503000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1079000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-154424000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-154424000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-154424000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.75
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.75
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.75
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,112204000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,112204000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,382000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,382000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,111822000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23411000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,129392000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,152803000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40981000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3719000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1037000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2682000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43663000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43447000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43447000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43447000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,89162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,88700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,467744000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,467744000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1758000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1758000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,465986000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,74389000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,501173000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,575562000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-109576000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10753000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2720000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-117609000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-117393000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-117393000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-117393000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,89162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.37
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.37
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,88700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.37
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,414602000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,414602000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30169000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30169000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,384433000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57739000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,181024000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,238763000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,145670000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11495000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11111000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,134559000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-335848000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,470407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,470407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,470407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94685000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.97
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115382000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.22
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.97
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1378477000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1378477000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,84455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,84455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1294022000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,210755000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,625554000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,836309000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,457713000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,45304000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43292000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,414421000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-335848000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,750269000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,750269000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,750269000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94685000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,7.92
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115382000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.75
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.92
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,427687000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,427687000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20145000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20145000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,407542000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46883000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,158295000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,205178000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,202364000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11413000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10896000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,191468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,191468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,191468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,191468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.02
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.72
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 07:14:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.02
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,963875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,963875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,54286000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,54286000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,909589000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,153016000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,444530000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,597546000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,312043000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,33809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32181000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,279862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,279862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,279862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,279862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.95
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.53
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.95
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1086852000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1086852000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,57275000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,57275000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1029577000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,189365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,573571000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,762936000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,266641000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,43264000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2427000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-40837000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,225804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-615000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,226419000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,226419000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,226419000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.36
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.94
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.36
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,304399000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,304399000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21843000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21843000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,282556000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47705000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,147373000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,195078000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,87478000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11236000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,501000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10735000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,76743000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76743000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,76743000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,76743000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94589000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110167000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.7
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 07:10:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,536188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,536188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34141000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34141000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,502047000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,106133000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,286235000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,392368000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,109679000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22396000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1111000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21285000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,88394000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,88394000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,88394000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,88394000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94589000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.93
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110167000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.93
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,761998000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,761998000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37580000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37580000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,724418000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,175398000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,543200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,718598000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5820000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,35912000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2625000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-33287000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27467000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-53000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27414000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27414000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27414000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94589000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110167000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,231789000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,231789000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12298000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12298000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,219491000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58428000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,138862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,197290000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22201000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11160000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,610000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10550000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,93446000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107734000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,97100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,565409000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,565409000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16132000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16132000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,549277000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,152278000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,538976000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,691254000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-141977000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28723000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3122000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25601000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-167578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-916000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-166662000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-166662000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-166662000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,93446000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.84
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107734000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.85
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,97100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.84
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2104745000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2104745000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,155355000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,155355000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1949390000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,346393000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,859947000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1206340000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,743050000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,46437000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-231000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-46668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,696382000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,282644000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,413738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,413738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,413738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97917000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.23
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,111290000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.72
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.33
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,610412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,610412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,48114000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,48114000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,562298000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,99063000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,268140000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,367203000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,195095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11661000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-849000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13920000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,181175000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,94993000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,86182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,86182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,86182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97917000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,111290000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.78
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1494333000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1494333000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,107241000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,107241000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1387092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,247330000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,591807000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,839137000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,547955000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,34776000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,618000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32748000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,515207000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,187651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,327556000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,327556000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,327556000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98226000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.35
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116713000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.94
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.35
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1908935000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1908935000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,137410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,137410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1771525000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,305069000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,772831000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1077900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,693625000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,46271000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-218000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2630000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43859000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,649766000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-148197000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,797963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,797963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,797963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98226000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.32
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116713000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.16
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.32
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,597027000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,597027000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38573000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38573000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,558454000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,97607000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,224045000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,321652000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,236802000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11736000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,618000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11118000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,225684000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,84378000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,141306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,141306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,141306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98226000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.44
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116713000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 07:06:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.44
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,897306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,897306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,68668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,68668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,828638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,149723000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,367762000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,517485000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,311153000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23040000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21630000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,289523000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,103273000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,186250000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,186250000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,186250000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.91
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,111060000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.91
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1739595000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1739595000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,118982000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,118982000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1620613000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,254345000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,707081000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,961426000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,659187000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,45948000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,299000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43637000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,615550000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-232575000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,848125000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,848125000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,848125000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.9
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,111060000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.63
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.9
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,457642000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,457642000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39613000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39613000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,418029000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,72463000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,187463000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,259926000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,158103000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,954000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10411000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,147692000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,60316000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,87376000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,87376000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,87376000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,111060000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 06:52:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,439664000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,439664000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29055000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29055000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,410609000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,77260000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,180299000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,257559000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,153050000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,456000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11219000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,141831000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,42957000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98874000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,98874000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,98874000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,96878000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.02
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,109369000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.02
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1586352000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1586352000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,101212000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,101212000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1485140000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,229587000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,666991000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,896578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,588562000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,45819000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-154000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43961000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,544601000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-292891000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,837492000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,837492000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,837492000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,96878000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.82
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,109369000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.54
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.82
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2787616000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,31941000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2819557000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,205018000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,205018000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2614539000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,519267000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1271353000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1790620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,823919000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-37372000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25312000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-62684000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,761235000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,423109000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,338126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,338126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,338126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100612000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.36
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113413000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.98
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.36
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,770388000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,31941000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,802329000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,59474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,59474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,742855000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,175307000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,351745000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,527052000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,215803000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-41809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-37372000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-30517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26080000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,189723000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,99628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,90095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,90095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100612000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113413000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.99
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,725788000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,725788000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,55593000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,55593000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,670195000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,144003000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,337728000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,481731000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,188464000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9232000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2591000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6641000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,181823000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,98448000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,83375000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,83375000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,83375000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100796000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117423000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 07:24:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.79
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2017228000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2017228000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,145544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,145544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1871684000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,343960000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,919608000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1263568000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,608116000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5205000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-36604000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,571512000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,323481000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,248031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,248031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,248031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100796000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.48
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117423000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.19
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.37
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2627640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2627640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,193658000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,193658000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2433982000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,443023000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1187748000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1630771000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,803211000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,53470000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4356000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-50524000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,752687000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,418474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,334213000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,334213000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,334213000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100796000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.36
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117423000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.97
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.35
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1291440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1291440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,89951000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,89951000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1201489000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,199957000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,581880000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,781837000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,419652000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,32577000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2614000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,389689000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,225033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,164656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,164656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,164656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100391000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.65
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113032000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.46
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.58
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2498879000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2498879000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,176638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,176638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2322241000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,396627000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1074065000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1470692000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,851549000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55974000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2383000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-55001000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,796548000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,404404000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,392144000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,392144000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,392144000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100391000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.97
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113032000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.49
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,665700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,665700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46379000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46379000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,619321000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,96730000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,294501000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,391231000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,228090000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20964000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1677000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19287000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,208803000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,112452000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,96351000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,96351000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,96351000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100391000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.96
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113032000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.85
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 07:21:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.92
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2290821000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2290821000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,169872000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,169872000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2120949000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,372360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,967027000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1339387000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,781562000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,46375000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-456000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,706000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-46125000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,735437000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,352268000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,383169000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,383169000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,383169000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98709000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.9
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112151000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.43
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.97
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,625740000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,625740000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,582168000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,103227000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,287379000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,390606000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,191562000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11613000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,937000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10676000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,180886000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,112581000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,68305000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,68305000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,68305000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98709000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112151000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.66
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4028839000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,74889000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4103728000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,392709000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,392709000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3711019000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,838526000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1620577000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2459103000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1251916000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-14241000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26819000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1225097000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,589041000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,636056000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,636056000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,636056000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103061000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,6.17
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115230000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.52
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.17
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1080005000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,18072000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1098077000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,110831000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,110831000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,987246000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,294954000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,461210000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,756164000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,231082000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18214000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14421000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3793000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,227289000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,72295000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,154994000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,154994000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,154994000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103061000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.5
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115230000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.35
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.5
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1119893000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,17529000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1137422000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,109083000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,109083000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1028339000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,209993000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,425924000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,635917000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,392422000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2140000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1273000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,867000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,393289000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,182891000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,210398000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,210398000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,210398000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.04
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115944000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.82
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 07:32:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.04
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2948834000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,56817000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3005651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,281878000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,281878000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2723773000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,543572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1159367000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1702939000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1020834000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3973000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26999000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23026000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,997808000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,516746000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,481062000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,481062000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,481062000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.67
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115944000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.17
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.67
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3719222000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,88758000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3807980000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,341352000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,341352000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3466628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,718879000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1511112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2229991000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1236637000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-41809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-33399000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-57516000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49106000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1187531000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,616374000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,571157000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,571157000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,571157000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.55
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115944000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.96
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.66
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,987166000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,11451000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,998617000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,88840000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,88840000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,909777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,174588000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,390330000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,564918000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,344859000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1653000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18516000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16863000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,327996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,133353000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,194643000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,194643000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,194643000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102886000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.89
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115259000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 07:31:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.89
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1828941000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,39288000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1868229000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,172795000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,172795000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1695434000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,333579000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,733443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1067022000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,628412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25726000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23893000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,604519000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,333855000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,270664000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,270664000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,270664000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102886000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.63
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115259000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.35
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.63
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3325117000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,71229000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3396346000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,287862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,287862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3108484000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,652889000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1422916000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2075805000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1032679000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-32577000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-35539000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-53652000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-56614000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,976065000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,531931000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,444134000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,444134000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,444134000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102886000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.34
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115259000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.87
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.41
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,841775000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,27837000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,869612000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,83955000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,83955000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,785657000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,158991000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,343113000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,502104000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,283553000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,180000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7210000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7030000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,276523000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,200502000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76021000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,76021000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,76021000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102227000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114519000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3003651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,59778000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3063429000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,245401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,245401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2818028000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,575031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1327087000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1902118000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,915910000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-11613000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-37192000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-33459000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-59038000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,856872000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,511030000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,345842000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,345842000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,345842000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102227000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.41
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114519000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.03
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.44
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4741325000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,119102000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4860427000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,299694000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,299694000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4560733000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1177697000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2052295000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3229992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1330741000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7195000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6269000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-926000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1329815000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,434293000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,895522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,895522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,895522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104719000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,8.55
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116367000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.7
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.55
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1175170000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,51657000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1226827000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,74681000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,74681000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1152146000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,325937000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,479206000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,805143000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,347003000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2808000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5476000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,341527000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,88412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,253115000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,253115000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,253115000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104719000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.4
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116367000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.15
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.4
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1193158000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,26964000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1220122000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44228000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44228000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1175894000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,270045000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,543047000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,813092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,362802000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-496000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3575000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3079000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,365881000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,101077000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,264804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,264804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,264804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.53
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116466000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.27
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 07:54:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.53
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3566155000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,67445000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3633600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,225013000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,225013000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3408587000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,851760000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1573089000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2424849000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,983738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-4387000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8937000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4550000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,988288000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,345881000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,642407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,642407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,642407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.15
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116466000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.55
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.15
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4646160000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,85517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4731677000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,335844000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,335844000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4395833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1146714000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2034299000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3181013000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1214820000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-22601000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,23358000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,757000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1215577000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,418176000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,797401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,797401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,797401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.65
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116466000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.9
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.65
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1189529000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,23100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1212629000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,69033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,69033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1143596000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,292038000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,559930000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,851968000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,291628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1251000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1879000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,292256000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,96038000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,196218000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,196218000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,196218000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104633000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.88
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116231000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 07:46:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.88
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2372997000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,40481000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2413478000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,180785000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,180785000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2232693000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,581715000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1030042000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1611757000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,620936000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3891000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5362000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1471000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,622407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,244804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,377603000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,377603000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,377603000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104633000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.62
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116231000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.28
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.62
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4572895000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,76082000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4648977000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,400699000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,400699000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4248278000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1086662000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1917176000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3003838000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1244440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-19965000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18510000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1242985000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,499990000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,742995000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,742995000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,742995000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104633000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.16
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116231000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.45
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.16
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1183468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,17381000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1200849000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,111752000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,111752000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1089097000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,289677000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,470112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,759789000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,329308000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3483000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,843000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,330151000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,148766000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,181385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,181385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,181385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104290000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.74
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114228000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.59
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.74
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4370532000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,64433000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4434965000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,420506000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,420506000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4014459000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,969212000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1747576000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2716788000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1297671000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-17061000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1885000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18946000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1278725000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,537305000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,741420000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,741420000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,741420000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104290000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.17
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114228000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.45
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.17
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5872200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5872200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,397100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,397100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5475100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1320400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2075100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3395500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2079600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2078500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,880000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1198500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1198500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1198500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,11.27
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.34
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,11.27
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1638860000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-56440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1582420000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,105779000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,105779000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1476641000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,409880000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,527941000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,937821000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,538820000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6016000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21952000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15936000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,554756000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,381248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,173508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,173508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,173508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.61
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.52
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.61
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1500673000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1500673000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,104232000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,104232000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1396441000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,306766000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,529749000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,836515000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,559926000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11861000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5679000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,565605000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,177288000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,388317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,388317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,388317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106706000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.64
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117028000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.32
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 07:56:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.64
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4233340000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,56440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4289780000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,291321000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,291321000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3998459000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,910520000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1547159000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2457679000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1540780000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19084000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2048000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17036000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1523744000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,498752000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1024992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1024992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1024992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106706000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.66
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117028000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.82
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.66
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5408510000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,108097000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5516607000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,366002000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,366002000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5150605000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1236457000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2026365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3262822000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1887783000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19084000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2808000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22512000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1865271000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,587164000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1278107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1278107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1278107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106706000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,12.06
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117028000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.97
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.06
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1470116000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1470116000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,102921000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,102921000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1367195000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,306908000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,509975000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,816883000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,550312000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-19061000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24462000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,525850000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,138106000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,387744000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,387744000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,387744000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106034000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.66
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116137000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.34
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:11:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.66
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2732667000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,56440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2789107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,187089000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,187089000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2602018000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,603754000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1017410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1621164000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,980854000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12902000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9813000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22715000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,958139000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,321464000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,636675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,636675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,636675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106034000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.02
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116137000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.5
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.02
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5100995000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,135061000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5236056000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,305998000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,305998000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4930058000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1199736000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2039663000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3239399000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1690659000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12902000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3304000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8906000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1665547000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,510953000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1154594000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1154594000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1154594000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106034000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,10.95
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116137000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.92
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.95
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1262551000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,56440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1318991000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,84168000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,84168000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1234823000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,296846000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,507435000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,804281000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,430542000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7501000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1747000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,432289000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,183358000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,248931000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,248931000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,248931000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.36
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115106000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.16
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.36
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4820408000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,158161000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4978569000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,272110000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,272110000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4706459000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1184866000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2089618000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3274484000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1431975000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7501000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-4555000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12034000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1431953000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,468885000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,963068000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,963068000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,963068000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.17
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115106000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.27
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.17
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6710800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6710800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,434100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,434100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6276700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1556200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2186100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3742300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2534400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,47300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,19100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2553500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,109100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2444400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2444400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2444400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,22.65
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,21.29
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,22.65
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1927778000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1927778000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,117139000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,117139000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1810639000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,491316000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,601211000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1092527000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,718112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7482000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34504000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-41986000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,676126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-144162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,820288000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,820288000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,820288000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.59
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.14
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.59
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1663500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1663500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,110400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,110400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1553100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,369200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,557000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,926200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,626900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,635900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,594700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,594700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,594700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.5
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.17
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 07:47:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.5
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4783022000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4783022000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,316961000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,316961000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4466061000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1064884000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1584889000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2649773000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1816288000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20718000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,81804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,61086000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1877374000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,253262000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1624112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1624112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1624112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,15.06
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,14.15
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,15.06
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6421882000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-56440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6365442000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,422740000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,422740000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5942702000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1474764000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2112830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3587594000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2355108000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26734000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,103756000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,77022000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2432130000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,634510000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1797620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1797620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1797620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,16.67
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,15.67
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,16.67
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1608022000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1608022000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,91661000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,91661000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1516361000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,364884000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,529289000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,894173000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,622188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6918000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,40804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,33886000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,656074000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,104662000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,551412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,551412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,551412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.12
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114477000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.82
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 16:11:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.12
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3119522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3119522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,206561000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,206561000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2912961000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,695684000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1027889000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1723573000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1189388000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13318000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,65404000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,52086000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1241474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,212062000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1029412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1029412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1029412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.56
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114477000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.98
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.56
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6259055000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-56440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6202615000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,416572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,416572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5786043000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1412330000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2085579000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3497909000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2288134000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25516000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,99217000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,73701000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2361835000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,770598000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1591237000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1591237000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1591237000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,14.81
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114477000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,13.82
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,14.81
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1511500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1511500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,114900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,114900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1396600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,330800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,498600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,829400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,567200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,585400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,107400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,478000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,478000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,478000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.44
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.16
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.44
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6121149000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-56440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6064709000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,427832000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,427832000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5636877000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1354354000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2066265000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3420619000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2216258000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23999000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39352000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15353000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2231611000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,804042000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1427569000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1427569000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1427569000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,13.35
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.34
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,13.35
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2508700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2508700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,231000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,231000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2277700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,706500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,838800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,56700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1602000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,675700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,220800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,214100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,889800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,97800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,792000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,792000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,792000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.26
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.93
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.26
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7863400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7863400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,782200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,782200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7081200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1834800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3036600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4871400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2209800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,249500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,219300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2429100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,313300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2115800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2115800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2115800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,19.38
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,18.46
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,19.38
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5354700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5354700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,551200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,551200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4803500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1128300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2197800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-56700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3269400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1534100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,28700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1539300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,215500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1323800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1323800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1323800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,12.12
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,11.53
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.12
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2048400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2048400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,226600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,226600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1821800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,419900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,663400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1083300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,738500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,37800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,768500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,98900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,669600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,669600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,669600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,6.12
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.86
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 07:47:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.12
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7282478000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7282478000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,668339000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,668339000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6614139000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1619616000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2799011000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-56700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4361927000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2252212000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30982000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-36786000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2215426000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,71338000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2144088000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2144088000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2144088000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,19.71
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,18.67
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,19.71
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1933700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1933700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,152500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,152500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1781200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,417300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1048300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1465600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,315600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-82900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-90900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,224700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,31600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,193100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,193100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,193100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.77
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.68
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 07:55:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.77
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3306300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3306300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,324600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,324600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2981700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,708400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1534400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-56700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2186100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,795600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,770800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,116600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,654200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,654200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,654200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.67
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6897578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6897578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,552139000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,552139000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6345439000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1568916000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2692611000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-56700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4204827000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2140612000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30582000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-27204000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-57786000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2082826000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2069188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2069188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2069188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,19.09
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,17.98
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,19.09
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1372600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1372600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,172100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,172100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1200500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,291100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,486100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-56700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,720500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,480000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,73800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,66100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,546100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,85000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,461100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,461100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,461100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.23
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.99
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.23
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6571900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6571900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,491300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,491300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6080600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1516500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2173600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-56700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3633400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2447200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,96500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,67000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2514200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,86700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2427500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2427500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2427500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,22.44
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,21.12
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,22.44
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8319000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8319000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,827400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,827400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7491600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1911000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3134400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,16300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5061700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2429900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,150300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,121700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2551600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,272300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2279300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2279300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2279300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,20.84
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,19.9
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,20.84
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1828200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1828200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,217300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,217300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1610900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,367300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,583900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-40400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,910800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,700100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-31500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,668600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,44000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,624600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,624600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,624600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.69
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.43
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.69
